Boehringer Ingelheim PRRS Up and Down

	Data from large commercial field trials reveals increased average daily gain and reduced mortality among vaccinated growing pigs at risk to PRRS exposure. Ingelvac® PRRS MLV and Ingelvac® PRRS ATP, when administered to healthy, yet susceptible, pigs four weeks prior to virus exposure, help reduce the incidence of PRRS-induced disease. But not every herd has the same PRRS risk. Diagnostic profiling can accurately assess a herd’s exposure pattern to the PRRS virus to determine if PRRS vaccination is advisable. And for a limited time, Boehringer Ingelheim is offering this diagnostic service to you at no charge. Call us at 1-800-325-9167.


	Vaccinating Growing Pigs for PRRS Has Its Ups and Downs		PRRS Vaccination for Growing Pigs


	Evaluation of the Efficacy of Ingelvac® PRRS MLV and Ingelvac® PRRS ATP in Multiple Heterologous Respiratory Challenge Studies		Evaluation of the Effi cacy of Ingelvac® PRRS ATP Against Three Different Challenge Strains of PRRS.


	Click here for INGELVAC® PRRS-ATP Product Information.		Click here for INGELVAC® PRRS-MLV Product Information.

	Call us at 1-800-325-9167.

Subscribe to Boehringer Ingelheim's Swine Division Product Announcements & eNewsletters. (Fields Marked with an * are required)

Name*

eMail*

Please Select a Subscriber Type (check all applicable items)

veterinarian
animal health dealer
producer
farrow-to-finish
farrow-to-wean
wean-to-finish
finish only
academia
student
other